Form 4 for ELVN Enliven Therapeutics, Inc.
Accepted 2024-06-20 00:00:00 ET · period of report 2024-06-17 · accession 0001415889-24-017715 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-20 | 2024-06-17 | ELVN | Heyman Richard A. | Dir | S - Sale | $21.48 | -1,270 | 134.6K | -0.9% | -$27.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-17 | S | D | 1,270 | $21.48 | 134,615 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $21.22 to $22.0783. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |